$23.45
0[0.00%]
Last update: 4:00PM Get Real Time Here
Pharvaris
(NASDAQ:PHVS)Pharvaris Stock (NASDAQ:PHVS), Analyst Ratings, Price Targets, Predictions
Pharvaris NV has a consensus price target of $30, established from looking at the 34 latest analyst ratings. The last 3 analyst ratings were released from Morgan Stanley, Morgan Stanley, and JMP Securities on April 22, 2024, April 15, 2024, and April 11, 2024. With an average price target of $39.33 between Morgan Stanley, Morgan Stanley, and JMP Securities, there's an implied 67.73% upside for Pharvaris NV from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Morgan Stanley
JMP Securities
Wedbush
B of A Securities
SVB Leerink
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Pharvaris
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/22/2024 | PHVS | Buy Now | Pharvaris | $23.45 | 44.99% | Morgan Stanley | Matthew Harrison | $34 → $34 | Maintains | Overweight | Get Alert |
| 04/15/2024 | PHVS | Buy Now | Pharvaris | $23.45 | 44.99% | Morgan Stanley | Matthew Harrison | $35 → $34 | Maintains | Overweight | Get Alert |
| 04/11/2024 | PHVS | Buy Now | Pharvaris | $23.45 | 113.22% | JMP Securities | Jonathan Wolleben | $49 → $50 | Maintains | Market Outperform | Get Alert |
| 04/11/2024 | PHVS | Buy Now | Pharvaris | $23.45 | 49.25% | Wedbush | Laura Chico | → $35 | Reiterates | Outperform → Outperform | Get Alert |
| 03/19/2024 | PHVS | Buy Now | Pharvaris | $23.45 | 49.25% | Wedbush | Laura Chico | → $35 | Reiterates | Outperform → Outperform | Get Alert |
| 02/14/2024 | PHVS | Buy Now | Pharvaris | $23.45 | 108.96% | JMP Securities | Jonathan Wolleben | → $49 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 01/23/2024 | PHVS | Buy Now | Pharvaris | $23.45 | 108.96% | JMP Securities | Jonathan Wolleben | $40 → $49 | Maintains | Market Outperform | Get Alert |
| 12/07/2023 | PHVS | Buy Now | Pharvaris | $23.45 | -53.09% | B of A Securities | Tazeen Ahmad | $8 → $11 | Maintains | Underperform | Get Alert |
| 12/07/2023 | PHVS | Buy Now | Pharvaris | $23.45 | 49.25% | Morgan Stanley | Matthew Harrison | — | Maintains | Overweight | Get Alert |
| 11/14/2023 | PHVS | Buy Now | Pharvaris | $23.45 | 36.46% | Morgan Stanley | Matthew Harrison | $34 → $32 | Maintains | Overweight | Get Alert |
| 11/03/2023 | PHVS | Buy Now | Pharvaris | $23.45 | 2.35% | Wedbush | Laura Chico | $27 → $24 | Maintains | Outperform | Get Alert |
| 09/25/2023 | PHVS | Buy Now | Pharvaris | $23.45 | 15.14% | Wedbush | Laura Chico | → $27 | Initiates | → Outperform | Get Alert |
| 08/15/2023 | PHVS | Buy Now | Pharvaris | $23.45 | 44.99% | Morgan Stanley | Matthew Harrison | $10 → $34 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 08/01/2023 | PHVS | Buy Now | Pharvaris | $23.45 | -57.36% | Morgan Stanley | Matthew Harrison | $10 → $10 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 07/31/2023 | PHVS | Buy Now | Pharvaris | $23.45 | -57.36% | Morgan Stanley | Matthew Harrison | — | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 07/24/2023 | PHVS | Buy Now | Pharvaris | $23.45 | -57.36% | Morgan Stanley | Matthew Harrison | $10 → $10 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 07/17/2023 | PHVS | Buy Now | Pharvaris | $23.45 | -57.36% | Morgan Stanley | Matthew Harrison | $10 → $10 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 06/26/2023 | PHVS | Buy Now | Pharvaris | $23.45 | -57.36% | Morgan Stanley | Matthew Harrison | $10 → $10 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 06/20/2023 | PHVS | Buy Now | Pharvaris | $23.45 | -57.36% | Morgan Stanley | Matthew Harrison | → $10 | Reiterates | → Equal-Weight | Get Alert |
FAQ
What is the target price for Pharvaris (PHVS)?
The latest price target for Pharvaris (NASDAQ: PHVS) was reported by Morgan Stanley on April 22, 2024. The analyst firm set a price target for $34.00 expecting PHVS to rise to within 12 months (a possible 44.99% upside). 21 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Pharvaris (PHVS)?
The latest analyst rating for Pharvaris (NASDAQ: PHVS) was provided by Morgan Stanley, and Pharvaris maintained their overweight rating.
When was the last upgrade for Pharvaris (PHVS)?
The last upgrade for Pharvaris NV happened on August 15, 2023 when Morgan Stanley raised their price target to $34. Morgan Stanley previously had an equal-weight for Pharvaris NV.
When was the last downgrade for Pharvaris (PHVS)?
The last downgrade for Pharvaris NV happened on August 23, 2022 when Morgan Stanley changed their price target from $40 to $10 for Pharvaris NV.
When is the next analyst rating going to be posted or updated for Pharvaris (PHVS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Pharvaris, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Pharvaris was filed on April 22, 2024 so you should expect the next rating to be made available sometime around April 22, 2025.
Is the Analyst Rating Pharvaris (PHVS) correct?
While ratings are subjective and will change, the latest Pharvaris (PHVS) rating was a maintained with a price target of $34.00 to $34.00. The current price Pharvaris (PHVS) is trading at is $23.45, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.